Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission

Journal of Neuroscience

Volumn 26, Issue 35, 2006, Pages 8955-8964

  Jennings, Katie A ^a   Loder, Merewyn K ^b   Sheward, W John ^b   Pei, Qi ^a   Deacon, Robert M J ^a   Benson, Matthew A ^a   Olverman, Henry J ^b   Hastie, Nicholas D ^c   Harmar, Anthony J ^b   Shen, Sanbing ^b,e   Sharp, Trevor ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anxiety; Microdialysis; Polymorphism; Serotonergic; Serotonin; Serotonin transporter

Indexed keywords

MESSENGER RNA; NEUROTRANSMITTER; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BINDING SITE; CONTROLLED STUDY; GENETIC ENGINEERING; MAZE TEST; MICRODIALYSIS; MOUSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAPHE NUCLEUS; TRANSGENIC ANIMAL;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BINDING SITES; BRAIN; EXTRACELLULAR SPACE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; PHENOTYPE; RNA, MESSENGER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION;

EID: 33748271285     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5356-05.2006     Document Type: Article

References (57)

1. Bajjalieh S (2001) SNAREs take the stage: a prime time to trigger neurotransmitter secretion. Trends Neurosci 24:678-680.
2. Bengel D, Johren O, Andrews AM, Heils A, Mossner R, Sanvitto GL, Saavedra JM, Lesch KP, Murphy DL (1997) Cellular localization and expression of the serotonin transporter in mouse brain. Brain Res 778:338-345.
3. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53:649-655.
4. Blakely RD, De Felice LJ, Hartzell HC (1994) Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196:263-281.
5. Briley M, Chopin P, Moret C (1990) Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology (Berl) 101:187-189.
6. 1A receptor antagonist co-administration. J Neurochem 85:1480-1487.
7. Cohen-Tannoudji M, Babinet C, Morello D (2000) lacZ and ubiquitously expressed genes: should divorce be pronounced? Transgenic Res 9:233-235.
8. Critchley MA, Njung'e K, Handley SL (1992) Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacology (Berl) 106:484-490.
9. Deacon RM, Croucher A, Rawlins JN (2002) Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behav Brain Res 132:203-213.
10. De Souza EB, Kuyatt BL (1987) Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain. Synapse 1:488-496.
11. Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, Murphy DL, Lanfumey L, Hamon M, Martres MP (2000) Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 12:2299-2310.
12. Franklin K, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic.
13. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 115:1064-1070.
14. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83-87.
15. Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J, Lesch KP, Hamer D, Murphy DL (2000) Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 96:202-216.
16. Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319-395.
17. Gross C, Hen R (2004) The developmental origins of anxiety. Nat Rev Neurosci 5:545-552.
18. Handley SL (1995) 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 66:103-148.
19. Hanna GL, Himle JA, Curtis GC, Koram DQ, Veenstra-VanderWeele J, Leventhal BL, Cook Jr EH (1998) Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology 18:102-111.
20. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400-403.
21. Hatip-Al-Khatib I, Mishima K, Iwasaki K, Fujiwara M (2001) Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine. Brain Res 902:108-118.
22. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624.
23. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger DR (2000) A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 47:643-649.
24. Hernandez I, Sokolov BP (1997) Abnormal expression of serotonin transporter mRNA in the frontal and temporal cortex of schizophrenics. Mol Psychiatry 2:57-64.
25. Heslop KE, Curzon G (1994) Depletion and repletion of cortical tissue and dialysate 5-HT after reserpine. Neuropharmacology 33:567-573.
26. Holmes A, Yang RJ, Lesch KP, Crawley JN, Murphy DL (2003a) Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28:2077-2088.
27. Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN (2003b) Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2:365-380.
28. Jennings KA, Sheward WJ, Harmar AJ, Sharp T (2003) In vivo evidence that mice overexpressing the 5-HT transporter have decreased cortical 5-HT release. Proceedings of the 10th International Conference in In Vivo Methods, Stockholm, June.
29. Kavalali ET (2002) SNARE interactions in membrane trafficking: a perspective from mammalian central synapses. BioEssays 24:926-936.
30. Kilic F, Murphy DL, Rudnick G (2003) A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 64:440-446.
31. Kim DK, Tolliver TJ, Huang SJ, Martin BJ, Andrews AM, Wichems C, Holmes A, Lesch KP, Murphy DL (2005) Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49:798-810.
32. Le Marec N, Hebert C, Amdiss F, Botez MI, Reader TA (1998) Regional distribution of 5-HT transporters in the brain of wild type and "Purkinje cell degeneration" mutant mice: a quantitative autoradiographic study with [3H]citalopram. J Chem Neuroanat 15:155-171.
33. Lesch KP, Gutknecht L (2005) Pharmacogenetics of the serotonin transporter. Prog Neuropsychopharmacol Biol Psychiatry 29:1062-1073.
34. Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL (1993) Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Res Mol Brain Res 17:31-35.
35. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
36. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54:960-971.
37. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH (1998) Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155:207-213.
38. Loder MK, Shen S, Wren PB, Pei Q, Olverman HJ, Sharp T, Harmar AJ (2000) The production and analysis of transgenic mice over-expressing the human serotonin transporter. Soc Neurosci Abstr 26:146.6.
39. MacLean MR, Deuchar GA, Hicks MN, Morecroft I, Shen S, Sheward J, Colston J, Loughlin L, Nilsen M, Dempsie Y, Harmar A (2004) Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation 109:2150-2155.
40. Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS (1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry 44:1090-1098.
41. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V (2000) A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729-738.
42. Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP (1999) Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology (Berl) 144:67-76.
43. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, Smith CA (1996) Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347:731-733.
44. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL (2003) Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8:895:933-936.
45. Pei Q, Zetterstrom TS, Sprakes M, Tordera R, Sharp T (2003) Antidepressant drug treatment induces Arc gene expression in the rat brain. Neuroscience 121:975-982.
46. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8:828-834.
47. Pickel VM, Chan J (1999) Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens. J Neurosci 19:7356-7366.
48. Quick MW (2002) Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons. Int J Dev Neurosci 20:219-224.
49. Quick MW (2003) Regulating the conducting states of a mammalian serotonin transporter. Neuron 40:537-549.
50. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
51. Rothman JE (1996) The protein machinery of vesicle budding and fusion. Protein Sci 5:185-194.
52. Schedl A, Grimes B, Montoliu L (1996) YAC transfer by microinjection. Methods Mol Biol 54:293-306.
53. Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch KP, Murphy DL, Hall FS, Uhl GR, Sora I (2004) Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29:1790-1799.
54. Shen S, Battersby S, Weaver M, Clark E, Stephens K, Harmar AJ (2000a) Refined mapping of the human serotonin transporter (SLC6A4) gene within 17q11 adjacent to the CPD and NF1 genes. Eur J Hum Genet 8:75-78.
55. Shen S, Spratt C, Sheward WJ, Kallo I, West K, Morrison CF, Coen CW, Marston HM, Harmar AJ (2000b) Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice. Proc Natl Acad Sci USA 97:11575-11580.
56. Soderpalm B, Engel JA (1990) Serotonergic involvement in conflict behaviour. Eur Neuropsychopharmacol 1:7-13.
57. Sun Y, Zhang L, Johnston NL, Torrey EF, Yolken RH (2001) Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder. Br J Psychiatry Suppl 41:s137-s141.